Literature DB >> 11979930

[Ipriflavone in the treatment of osteoporosis].

Kazuya Makita1, Hiroaki Ohta.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11979930

Source DB:  PubMed          Journal:  Nihon Rinsho        ISSN： 0047-1852


× No keyword cloud information.
  2 in total

1.  The Protective and Therapeutic Effect of Exclusive and Combined Treatment with Alpha-ketoglutarate Sodium Salt and Ipriflavone on Bone Loss in Orchidectomized Rats.

Authors:  R P Radzki; M Bieńko; R Filip; S G Pierzynowski
Journal:  J Nutr Health Aging       Date:  2016       Impact factor: 4.075

2.  Ipriflavone as a non-steroidal glucocorticoid receptor antagonist ameliorates diabetic cognitive impairment in mice.

Authors:  Ruifang Nie; Jian Lu; Rui Xu; Juanzhen Yang; Xingyi Shen; Xingnan Ouyang; Danyang Zhu; Yujie Huang; Tong Zhao; Xuejian Zhao; Yin Lu; Minyi Qian; Jiaying Wang; Xu Shen
Journal:  Aging Cell       Date:  2022-02-16       Impact factor: 9.304
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.